Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID

from The Lancet Respiratory Medicine in conversation with · host The Lancet Respiratory Medicine

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Apr 7, 2022

Embed this episode

Attribution link and audio player

Ready to play

Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID

0:00 14:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Respiratory Medicine in conversation with?

This episode is 14 minutes long.

When was this The Lancet Respiratory Medicine in conversation with episode published?

This episode was published on April 7, 2022.

Can I download this The Lancet Respiratory Medicine in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!